Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Clinical Journal of the American Society of Nephrology : CJASN|March 18, 2022
Patient-Reported Symptoms and Subsequent Risk of Myocardial Infarction in Chronic Kidney DiseaseBenjamin Lidgard, Leila R Zelnick, Kevin D O'Brien, et al.Journal of the American Heart Association|May 27, 2022
Framingham and American College of Cardiology/American Heart Association Pooled Cohort Equations, High-Sensitivity Troponin T, and N-Terminal Pro-Brain-Type Natriuretic Peptide for Predicting Atherosclerotic Cardiovascular Events Across the Spectrum of Kidney DysfunctionBenjamin Lidgard, Leila R Zelnick, Alan Go, et al.Kidney360|April 3, 2025
Patterns in Heart Rate Variability during HemodialysisBenjamin Lidgard, Nisha Bansal, Nathaniel Ashford, et al.Kidney Medicine|September 21, 2023
High-Density Lipoprotein Lipidomics and Mortality in CKDBenjamin Lidgard, Andrew N Hoofnagle, Leila R Zelnick, et al.Clinical Chemistry|January 16, 2023
High-Density Lipoprotein Lipidomics in Chronic Kidney DiseaseBenjamin Lidgard, Andrew N Hoofnagle, Leila R Zelnick, et al.Journal of the American Heart Association|June 16, 2025
Association of Rate-Control and Antiarrhythmic Medication Use and Risk of Ischemic Stroke and Death in Patients on Dialysis With Atrial FibrillationBenjamin Lidgard, Dongjie X Fan, Leila R Zelnick, et al.Journal of the American Society of Nephrology : JASN|January 21, 2026
Association of Sphingolipids with All-Cause and Cardiovascular Death in Patients with Kidney Failure Treated with Maintenance HemodialysisBenjamin Lidgard, Andrew N Hoofnagle, Leila R Zelnick, et al.Ebiomedicine|August 27, 2023
Evaluation of plasma sphingolipids as mediators of the relationship between kidney disease and cardiovascular eventsBenjamin Lidgard, Nisha Bansal, Leila R Zelnick, et al.Kidney360|September 24, 2025
Circulating Sphingolipids and Incident CKD: The Strong Heart Family StudyAmanda M Fretts, Paul N Jensen, Benjamin Lidgard, et al.Heart Rhythm O2|June 11, 2025
Clinical and socioeconomic factors associated with recurrent atrial fibrillation after catheter ablation or antiarrhythmic drug therapyJaejin An, Nisha Bansal, Chengyi Zheng, et al.Pageof 2